Market closed
Maravai LifeSciences/$MRVI
Maravai LifeSciences shares are trading lower following the initiation of an investigation into potential claims against the company.
18 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Maravai LifeSciences
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Ticker
$MRVI
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
570
ISIN
US56600D1072
Website
MRVI Metrics
BasicAdvanced
$298M
-
-$1.05
-
-
Price and volume
Market cap
$298M
52-week high
$11.56
52-week low
$1.67
Average daily volume
2.2M
Financial strength
Current ratio
7.533
Quick ratio
6.372
Long term debt to equity
62.885
Total debt to equity
65.261
Interest coverage (TTM)
-1.52%
Management effectiveness
Return on assets (TTM)
-3.64%
Return on equity (TTM)
-37.98%
Valuation
Price to revenue (TTM)
1.101
Price to book
0.9
Price to tangible book (TTM)
-9.95
Price to free cash flow (TTM)
-12.049
Growth
Revenue change (TTM)
-10.30%
Earnings per share change (TTM)
16.41%
3-year revenue growth (CAGR)
-31.30%
3-year earnings per share growth (CAGR)
-12.37%
What the Analysts think about MRVI
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Maravai LifeSciences stock.
MRVI Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
MRVI Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
MRVI News
AllArticlesVideos
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out
Accesswire·2 days ago
Contact Levi & Korsinsky by May 5, 2025 Deadline to Join Class Action Against Maravai LifeSciences Holdings, Inc. (MRVI)
Accesswire·5 days ago
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewsWire·5 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Maravai LifeSciences stock?
Maravai LifeSciences (MRVI) has a market cap of $298M as of May 10, 2025.
What is the P/E ratio for Maravai LifeSciences stock?
The price to earnings (P/E) ratio for Maravai LifeSciences (MRVI) stock is 0 as of May 10, 2025.
Does Maravai LifeSciences stock pay dividends?
No, Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Maravai LifeSciences dividend payment date?
Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders.
What is the beta indicator for Maravai LifeSciences?
Maravai LifeSciences (MRVI) does not currently have a Beta indicator.